ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Linagliptin Impurity F
Linagliptin Impurity F
![Linagliptin Impurity F Structure](CAS/20180808/GIF/1673546-62-7.gif)
- CAS No.
- 1673546-62-7
- Chemical Name:
- Linagliptin Impurity F
- Synonyms
- Linagliptin-6;LIGLIPTIN IMPURITY Q;Linagliptin impurity 03;(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl;(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroace;(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide;Acetamide, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-2,2,2-trifluoro-;Linagliptin Impurity QQ: What is Linagliptin Impurity Q Q: What is the CAS Number of Linagliptin Impurity Q Q: What is the storage condition of Linagliptin Impurity Q;Linagliptin impurity 5/(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide;(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide (Linagliptin Impurity)
- CBNumber:
- CB13034786
- Molecular Formula:
- C27H27F3N8O3
- Molecular Weight:
- 568.55
- MOL File:
- 1673546-62-7.mol
- Modify Date:
- 2023/7/12 16:55:16
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302-H315-H319-H312-H332 |
Precautionary statements | P264-P280-P305+P351+P338-P337+P313P-P264-P270-P301+P312-P330-P501-P264-P280-P302+P352-P321-P332+P313-P362-P280-P302+P352-P312-P322-P363-P501-P261-P271-P304+P340-P312 |
Linagliptin Impurity F Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 60)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Varanous Labs Pvt Ltd | +91-7036248882 +91-7036248882 | Hyderabad, India | 1541 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
sgtlifesciences pvt ltd | +8617013299288 | China | 12382 | 58 | Inquiry |
Amadis Chemical Company Limited | 571-89925085 | China | 131980 | 58 | Inquiry |
Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 13028896684 | China | 56057 | 58 | Inquiry |
Jinan Baizhou Biological Technology Co., Ltd. | 0531-88987162 18615427082 | China | 497 | 58 | Inquiry |
Wuxi Minglu Medicine technology Co.,Ltd. | 0510-88726693 | China | 2216 | 58 | Inquiry |
Anhui Feixiang Pharmaceutical Technology Co., Ltd. | 13349001619 | CHINA | 1007 | 58 | Inquiry |
Shanghai Hao Zhun Biological Technology Co., Ltd. | 15800340161 | CHINA | 6846 | 58 | Inquiry |
1673546-62-7(Linagliptin Impurity F)Related Search:
Linagliptin Impurity JX
Linagliptin Impurity 10
Linagliptin Impurity H
Linagliptin Impurity C
2-QuinazolineMethanol, 4-Methyl-
Linagliptin N-Acetyl Impurity
Hydroxychloroquine O-Sulfate
Linagliptin Impurity D
Linagliptin Impurity K
Linagliptin iMpurity G
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate
Linagliptin iMpurity E
Hydroxychloroquine Sulfate EP Impurity A
DESETHYL HYDROXY CHLOROQUINE
chevron_left
1of3
chevron_right
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
Linagliptin Impurity QQ: What is
Linagliptin Impurity Q Q: What is the CAS Number of
Linagliptin Impurity Q Q: What is the storage condition of
Linagliptin Impurity Q
(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide (Linagliptin Impurity)
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroace
Acetamide, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-2,2,2-trifluoro-
Linagliptin-6
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl
Linagliptin impurity 5/(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
Linagliptin impurity 03
LIGLIPTIN IMPURITY Q
1673546-62-7
C27H27F3N8O3